PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 18582514-5 2008 The synthesis of dopamine from L-DOPA supplied to Muller cultures is inhibited by m-hydroxybenzylhydrazine, a DDC inhibitor. 3-hydroxybenzylhydrazine 82-106 dopa decarboxylase Mus musculus 110-113 32522342-6 2020 Importantly, treatment with AADC inhibitor NSD-1015 significantly ameliorated EAP-elicited pain response and catecholamine overactivity in MTA1-/- mice. 3-hydroxybenzylhydrazine 43-51 dopa decarboxylase Mus musculus 28-32 32671919-11 2020 In addition, l-dopa reduced corticotrophin-releasing hormone-stimulated adrenocorticotrophic hormone release from these cells after AADC activity was inhibited by NSD-1015. 3-hydroxybenzylhydrazine 163-171 dopa decarboxylase Mus musculus 132-136 27622543-5 2016 induced ptosis under treatment with 3-hydroxybenzylhydrazine, a centrally acting AADC inhibitor. 3-hydroxybenzylhydrazine 36-60 dopa decarboxylase Mus musculus 81-85